Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of different doses of dexmedetomidine in elderly patients undergoing ERCP
ChiCTR2100054726Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in pancreaticobiliary diseases (3 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Sedation score. Started Jan 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
pancreaticobiliary diseases
Beyond the preview
Go deeper on ChiCTR2100054726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054726.